Cite
HARVARD Citation
Ramos, K. et al. (2022). Two‐Part Phase 1 Multiple‐Ascending‐Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of TRV734 in Healthy Adults. Clinical pharmacology in drug development. 11 (1), pp. 51-62. [Online].